Published: 29-07-2017 21:06 | Updated: 29-07-2017 21:17
A new potential treatment strategy against childhood cancer with high mortality
Neuroblastoma is a cancer in children that originates in the sympathetic nervous system and has a high mortality. Current treatment includes chemotherapy and radiotherapy with their potentially severe side effects; there is therefore an urgent need for a new improved drug.
One potential treatment strategy is to use a drug to target deviant molecular signalling caused by changes in genes.
Cecilia Dyberg is a researcher at the Department of Women's and Children's Health and first author of a study which will be published in the journal PNAS.